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Abstract
Background: Deep vein thrombosis (DVT) is a major complication in critical care. There are various methods of
prophylaxis, but none of them fully prevent DVT, and each method has adverse effects. Electrical muscle stimulation
(EMS) could be a new effective approach to prevent DVT in intensive care unit (ICU) patients. We hypothesized that
EMS increases the venous flow of the lower limbs and has a prophylactic effect against the formation of DVT.
Methods: This study included 26 patients admitted to a single ICU. We enrolled patients who could not move
themselves due to spinal cord injury, head injury, central nervous system abnormalities, and sedation for mechanical
ventilation. The patients were randomly allocated to either the EMS group or the control group. Patients in the EMS
group received 30-min sessions of EMS applied to the bilateral lower extremities on arbitrary days within 14 days after
admission. The control patients received no EMS. The peak flow velocity and diameter of the popliteal vein (Pop.V) and
common femoral vein (CFV) were measured by ultrasound and then the volumes of venous flow were calculated
using a formula.
Results: There were no statistically significant differences in patient characteristics between the two groups except for the
mortality rate. In the EMS group, the median and interquartile range (IQR, 25th–75th percentile) of velocities of the Pop.V
and CFV were higher during EMS compared with at rest: 10.6 (8.0–14.8) vs 24.5 (15.1–37.8) cm/s and 17.0 (12.3–23.8) vs 24.
3 (17.0–33.0) cm/s, respectively (p < 0.05). The median (IQR) of volumes of venous flow of the Pop.V and CFV at rest and
during EMS were 4.2 (2.7–7.2) vs 8.6 (5.4–16.1) cm3/s and 12.9 (9.7–21.4) vs 20.8 (12.3–34.1) cm3/s, respectively (p < 0.05).
There were no major complications related to EMS.
Conclusions: EMS increased the venous flow of the lower limbs. EMS could be one potential method for venous
thromboprophylaxis.
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Background
Deep vein thrombosis (DVT) is one of the major com-
plications in critical care and sometimes leads to fatal
complication such as pulmonary embolism (PE). The in-
hospital mortality rate associated with PE in 2010 in the
USA was reported to be 4.4%, with 30-day and 6-month
rates up to 9.1 and 19.6%, respectively [1]. To prevent
accidental death by PE, it is important to prevent the
formation of DVT of the lower limbs during the inten-
sive care unit (ICU) stay.
Three factors are responsible for the formation of
DVT: venous blood stasis, endothelial injury, and hyper-
coagulability [2]. Patients with trauma or severe diseases
requiring mechanical ventilation are forced to be on
long-term bed rest, which causes venous blood stasis of
the lower limbs and puts them at high risk for DVT. It
is well known that range of mobility exercises and early
ambulation are important to prevent DVT. However,
such exercises are difficult and sometimes impossible
during intensive care. Most of the international guide-
lines recommend the use of intermittent pneumatic
compression (IPC) or compression stockings, or early
administration of anticoagulants to prevent DVT in
high-risk patients [3]. However, these prophylactic
methods cannot fully prevent DVT. A review suggested
that critically ill patients commonly develop DVT with
rates that vary from 10% to as high as 30% regardless of
the prophylactic methods [4]. There are also several is-
sues related to their use. IPC sometimes causes peroneal
nerve palsy or compartment syndrome due to incorrect
attachment [5], compression stockings sometimes cause
hemodynamic complication through incorrect use [6],
and anticoagulation involves a risk of major hemorrhage
[7]. Thus, a more effective and safer approach to DVT
prophylaxis is needed.
An electrical muscle stimulation (EMS) device has re-
cently been used for the rehabilitation of immobilized
people [8]. Circulating current between two electrodes
generated by EMS causes cyclic contraction of muscles
and results in rhythmic changes in venous blood flow,
which is expected to have a prophylactic effect on DVT
[9]. We have already shown that EMS prevented atrophy
of muscles during prolonged bed rest [10]. Thus, we hy-
pothesized that attaching EMS on the lower limbs might
have a potential to produce a similar effect of exercise
therapy even for the patients forced to be immobile for
prolonged periods. Some reports suggest that EMS may
have a preventive effect on DVT not only in healthy sub-
jects [8] but also in total knee/hip arthroplasty patients
[11, 12] and postoperative patients [13]. However, a re-
port on EMS use in patients with major trauma failed to
show a significant difference in the rate of DVT forma-
tion and venous flow parameters between the patients
with and without EMS [14]. There are few reports on
EMS aimed at the prophylaxis of DVT in critical care
settings, so the effect of EMS on the lower limbs is con-
troversial. Additionally, there are major differences be-
tween patients in ICU setting and patients in another
clinical settings; critically ill patients often were not able
to move themselves voluntarily and could not have com-
munication with others. They also have not only general
risk factors but also specific ICU risk factors of DVT,
like sedation, strong analgesia, vasopressors, or central
venous catheter. We think these differences may have
some effects on EMS. We hypothesized that EMS might
increase the venous flow of the lower limbs and might
have a prophylactic effect for formulating DVT even in
critically ill patients.
The purpose of this study was to evaluate the short-
term effects of EMS on venous blood flow of the lower
limbs in ICU patients by ultrasonography.
Methods
Enrollment
This study was approved by the institutional review
board of Osaka University Hospital (No. 13361-3), an
academic urban tertiary referral hospital in Suita, Japan.
The study was conducted in the ICU of the emergency
department of Osaka University Hospital from April
2014 to May 2015. The ICU has 17 beds and treated 885
patients in 2014. Formal written consent for participa-
tion in this study was obtained from each patient or
their next of kin.
We enrolled patients who could not voluntarily move
their lower limbs, that is, (a) patients with limitation of
lower limb motion due to traumatic brain injury, spinal
cord injury or cerebral infarction, or hemorrhage and (b)
sedated patients who were on mechanical ventilation for
more than 3 days. Patients were excluded if they were
under 16 years of age, were pregnant and parturient
women, suffered from cardiac arrest on admission, were
implanted with material containing metal parts, were on
a life-support device such as extracorporeal membrane
oxygenation, had a history of neurological disorder or
present evidence of venous thrombosis of the lower
limbs, received treatment for subarachnoid hemorrhage,
were complicated with congestive heart failure, were in
an unstable general condition, had local infection at the
sites of electrode application, or required rest of the
lower limbs because of fracture. We included 26 patients
in this study.
Study protocol
The risk of forming DVT was evaluated by the guideline
at Osaka University Hospital. Patients are stratified into
the high-risk group if they had a previous history of
DVT or PE, have an advanced cancer located in the pel-
vis, had hip/knee replacement surgery or spinal surgery,
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or have antiphospholipid antibody syndrome. The risk fac-
tors of forming DVT are as follows: age over 60, presence
of cancer not including advanced cancer located in the
pelvis, presence of inflammatory bowel diseases, suffering
from congestive heart failure or acute myocardial infarc-
tion, suffering from cerebral infarction or spinal cord in-
jury, presence of nephrotic syndrome, pregnant women,
obesity with body mass index (BMI) over 30 kg/m2, oral
contraceptive use, abnormality of clotting factors, tranex-
amic acid use, undergoing an operation in the dorsosacral
position, undergoing thoracoscopic surgery, undergoing
an operation of over 3 h in length, being forced to be on
bed rest for over 3 days, or being immobilized in a plaster
cast. Patients who had less than three risk factors were
stratified into the low-risk group, those with three risk fac-
tors into the moderate-risk group, and those with four risk
factors or more into the high-risk group.
Flowtron Excel (manufactured by ArjoHuntleigh, Malmö,
Sweden) was used for IPC. Prevention of DVT by IPC was
performed in the moderate- and high-risk patients if there
were no contraindications such as arteriosclerosis obliter-
ans. When a patient was evaluated as low-risk, the attend-
ing doctor decided to perform IPC or not. IPC was
attached to the bilateral lower legs. The compression pres-
sure was 40 mmHg. In this study, all patients were treated
with IPC. Unfractionated heparin was also administered
intravenously based on the attending doctor’s decision for
the high-risk patients. The dose of heparin was adjusted by
checking the activated partial thromboplastin time targeting
40 to 50 s. Compression stockings were not used in this
study. The prevention of DVT was continued until the first
ambulation or patient discharge. We assigned patients to
the EMS group or the control group by drawing lots from
a box containing 20 equally allocated lots.
Electrical muscle stimulation
Patients in the EMS group were positioned in the supine
position during EMS operation. We performed EMS
only once a day on arbitrary days within 14 days after
admission using the Torelete EM300 (distributed by
Toray International, Inc., Tokyo, Japan; manufactured by
ITO CO., LTD, Tokyo, Japan). EMS was performed at a
time to suit researcher’s convenience. The average num-
ber of EMS implementation was 6.6 times per each case
during study period (total EMS implementation was 93
times). Two pairs of EMS electrodes (PALS Platinum,
Axelgaard Manufacturing Co., Ltd., Fallbrook, CA) were
placed on the posterior calves and anteromedial thighs
of both extremities to deliver electricity to the calf and
quadriceps muscles (Fig. 1) with two EMS machines.
Stimulation from the two machines was administered at
the same time. The patients received one 30-min session
on each experimental day. The duration of stimulation
included 2 min for warm-up (pulse frequency 5 Hz,
pulse width 150 μs), 26 min for training (50 Hz, 200 μs),
and 2 min for cool-down (6 Hz, 150 μs). During the
Fig. 1 Position of the electrical muscle stimulation electrodes placed over the calf and quadriceps muscles
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training time, muscle stimulation was set to a total cycle
time of 19.2 s with an 8-s ON time, 8-s OFF time, 1.6-s
ramp-up time, and 1.6-s ramp-down time. The output
current of the device, which ranged from 20 to 50 mA,
was set to obtain slight visual movement of the ankle in
planter flexion. EMS was not conducted in the patients
in the control group during the study period. IPC device
was continuously activated between the EMS sessions in
the EMS group.
Doppler ultrasound measurements
The popliteal vein (Pop.V) and common femoral vein
(CFV) were imaged in the short-axis view using a Philips
CX50 CompactXtreme ultrasonic scanner (Philips Medical,
Seattle, WA) and L12-3 broadband linear array transducer
(Fig. 2). The measurements were taken at the popliteal
fossa, just proximal to the venous confluence of the lower
leg, and at the inguinal region, just below the inguinal liga-
ment. The patients were positioned in the supine position
with neutral positioning of the lower limbs when imaged of
the CFV, while with externally rotated and mildly flexed
knee when imaged of the Pop.V. In the EMS group, the
peak venous blood flow velocity (cm/s) and the diameter
(mm) of the Pop.V and CFV were recorded just before the
application of EMS and 10 min after initiating EMS. The
ultrasound probe was slightly angulated to face toward to
obtain Doppler signal. The Doppler angle was fixed to 60
degrees during measurements of blood velocity. In the con-
trol group, the measurements were made similarly when
the patient was at rest. All measurements were done by a
single intensive care specialist well trained in ultrasound
examination of the lower limbs.
After these measurements were obtained, we calcu-
lated the peak blood flow volume per second (cm3/s) in
the Pop.V and CFV by the following equation:
Peak blood flow volume per second (cm3/s) = radius
(cm) × radius (cm) × π (circular constant) × peak venous
blood flow velocity (cm/s).
In this formula, “radius” refers to the radius of Pop.V
or CFV, and “peak venous blood flow velocity” refers to
the peak venous blood flow velocity of Pop.V or CFV.
Patient data collection
Patient age, sex, height, body weight, BMI, Acute Physi-
ology and Chronic Health Evaluation (APACHE II)
score, Sequential Organ Failure Assessment (SOFA)
score, Injury Severity Score (ISS), and diagnosis were re-
corded on admission. Each patient’s final outcome, the
duration of mechanical ventilation, and side effects expe-
rienced with EMS were archived as well. We also con-
firmed the presence or absence of DVT by echography.
Statistical analysis
Patient baseline demographic and clinical variables are pre-
sented as median and interquartile range (IQR, 25th–75th
percentile). Data on patient sex, mortality, and presence or
absence of sedation and analgesia were compared between
the control group and EMS group using Fisher’s exact test.
Data on the risk classification for DVT was compared be-
tween the control group and EMS group using Pearson’s
chi-square test. Data on patient age, BMI, APACHE II
score, SOFA score, and ISS were compared between the
control group and EMS group using the Mann-Whitney U
test. The differences in blood flow velocity, vessel diameter,
and blood flow volume per second between the control
Pulse 
Wave
Fig. 2 Representative screen shot from pulsed Doppler ultrasound for measurement of the peak venous velocity and diameter of the popliteal vein
(Pop. V). Both were measured in the short-axis view. In this picture, the venous velocity was measured at the center of double line (denoted as equal
sign) continuously and then the pulse wave was figured. The peak velocity was measured at the top of the pulse wave (denoted as plus sign)
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group and the EMS group at rest and during EMS stimu-
lation were analyzed using the Kruskal-Wallis test. Statis-
tical analysis was performed using SPSS (version 22, SPSS,
Chicago, IL). A p value of <0.05 was considered statisti-
cally significant.
Results
Table 1 shows the patient characteristics of the two
groups, which comprised 26 patients (52 legs, control
group [n = 12], EMS group [n = 14]) and included 19
men and 7 women with a median (IQR) age of 70.0
(54.0–79.0) years. The diagnosis on admission was
trauma in 12 patients, stroke in 6 patients, sepsis in 4
patients, and acute respiratory failure in 4 patients. In-
juries in the 12 trauma patients were as follows: trau-
matic brain injury in 5, spinal cord injury in 5, pelvic
injury in 1, and abdominal injury in 1. The median
(IQR) of BMI, APACHE II score, SOFA score, and ISS
on admission were 22.7 (20.9–24.5), 16.5 (9.0–22.0), 4.0
(2.0–5.0), and 25.0 (18.5–33.5), respectively. There were
no statistical differences in these scores between the two
groups. There was also no statistical difference in the
probability of DVT between the two groups. The
mortality rate was 19.2%, which was significantly higher
in the control group.
The peak blood flow velocity, venous diameter, and
the peak blood flow volume per second of the Pop.V and
CFV are shown in Table 2. The data in the EMS group
was the summary of all the 93 sessions of EMS. The data
in the control group was the result of the 66 times mea-
surements. The peak venous flow velocities and peak
blood flow volume of the CFV and Pop.V in both of the
lower extremities were higher during EMS than at rest
in the EMS group patients. The peak venous flow vel-
ocity and blood flow volume of Pop.V tended to be
lower in the EMS group patients than in the control
group patients in the resting state, but the differences
were not statistically significant without the peak venous
flow velocity of right Pop.V. The peak venous flow
velocity of CFV tended to be lower in the EMS group
patients than in the control group patients in the resting
state, but the differences were not statistically significant.
The blood flow volume of CFV was significantly lower in
the EMS group patients than in the control group patients
in the resting state. No differences were identified in ven-
ous diameter between the control group patients and the
EMS group patients at rest or during EMS.
There were no major complications related to EMS.
There were no changes of blood pressure, heart rate,
and respiratory status during EMS (data not shown). No
patients complained of discomfort from application of
EMS. DVT and PE were detected in 1 patient in the con-
trol group, but no instances of DVT or PE occurred in
the EMS group.
Discussion
This is the first report, to our knowledge, to show the
increase of venous flow in the lower extremities during
EMS in the ICU setting by using ultrasound assessment.
We showed that the peak venous velocity and volume of
the CFV and Pop.V were significantly increased by EMS.
These findings may indicate that EMS could be a new
alternative for the prevention of DVT of the lower
extremities.
We observed increases in peak venous velocity of
nearly 2.2-fold in the Pop.V and 1.4-fold in the CFV with
EMS compared to those in the resting condition. The
maximum blood flow volume of the Pop.V rose by
nearly 2.2-fold and that of the CFV rose by 1.5-fold with
EMS compared to those in the resting condition. A pre-
vious report showed that IPC produces similar influ-
ences on velocity and volume of venous flow in the
lower limbs [15]. It has been thought that EMS activates
muscle pumping by contracting the lower extremity
skeletal muscles and thus produces more physiological
hemodynamic forces than IPC or compression stocking
[16, 17]. From this point of view, one report compared
Table 1 Patient characteristics in the control group and EMS
group
Control (n = 12) EMS (n = 14) p value






22.0 (20.2–24.2) 24.1 (21.3–28.1) 0.118
APACHE II
score
20.0 (14.0–23.0) 12.1 (9.0–20.0) 0.27
SOFA score 4.0 (2.5–5.0) 2.5 (1.0–4.0) 0.40





Mortality (%) 5 (42) 0 (0) 0.012
Sedation (%) 11 (92) 10 (71) 0.33










High risk 4 3
Moderate risk 5 8
Low risk 3 3
Values are presented as median (IQR)
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EMS with IPC in terms of the influences of lower limb
hemodynamics and showed that EMS led to more effect-
ive ejection of blood in conditions of venous stasis of
the lower limbs [18]. It was shown that EMS had a po-
tential for greater hemodynamic effect on the lower ex-
tremities than that of IPC. In addition, EMS did not
influence the diameter of the Pop.V or CFV in this
study. Another report addressed a similar finding in
major trauma patients [14]. These findings imply that
EMS intensifies the amount of venous return by activat-
ing muscle pumping without having a direct influence
on major veins of the lower extremities.
There were a lot of EMS study, but most of them con-
ducted EMS of calf muscles alone. Few reports address-
ing EMS effect with simultaneous stimulation of the
thigh and calf muscles in clinical settings. A report was
aimed to reveal EMS effect to reduce blood stasis during
arthroplasty. The authors mentioned that EMS of calf
muscles or thigh muscles alone was ineffective to put
out venous-pooling blood from lower extremities to the
central circulation [19]. We thought that simultaneous
stimulation was important to maximize this effect and it
would lead to prevent DVT more efficiently.
Blood flow velocity and the volume of Pop.V tended to
be lower in the EMS group patients than in the control
group patients in the resting state. These differences
were possibly a result of the difference in BMI between
the two groups: BMI values indicated that the EMS
group patients were more obese than the control group
patients. Obesity is one of the major risk factors for
DVT [20]. Several reports have shown that venous re-
turn in the inferior vena cava or in the femoral vein is
reduced in obese patients due to obesity-induced in-
creases in intra-abdominal pressure [21, 22]. Our results
were comparable with the results on venous flow of the
lower extremities in these reports.
There were no major complications related to EMS, and
it was well tolerated by the patients in this study. EMS is
reported to be a relatively safe procedure to use in adults
with advanced diseases, such as cancer or chronic ob-
structive pulmonary disease, and even in critically ill
patients. Some reports also revealed that it did not affect
the patient’s cardiorespiratory responses such as heart
rate, blood pressure, oxygen saturation, and respiration
rate. Compliance with its use is generally good, but it
sometimes causes muscle discomfort, pain, or superficial
burns, which may set limits to its use [23–25]. In intensive
care settings, most of the patients are sedated and pain is
controlled. This will relieve the pain associated with EMS
and may make EMS more tolerable for ICU patients than
non-ICU patients.
This study has several limitations. First, the efficacy of
EMS to prevent DVT was not directly proven. High peak
velocity and volume are not equal to better DVT protec-
tion. A large randomized controlled study is needed to elu-
cidate this point. Second, blood inflow, i.e., arterial flow, in
the lower extremities was not assessed in this study. It is
possible for arterial flow to be influenced by EMS, which
may have relevance to venous outflow. Arterial flow needs
to be measured during EMS as well. Third, it was not clear
which muscles should be stimulated, or when and how
long and at what intensity muscles should be stimulated
for DVT prophylaxis in ICU patients. These points also
need to be assessed in future studies.
Conclusions
EMS increased the venous flow of the lower limbs. This
modality may have a prophylactic effect on DVTand could
be one potential method for venous thromboprophylaxis,
particularly in ICU patients. Further study is needed to
confirm its optimal use.
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Table 2 Peak venous flow velocities, venous diameters, and
peak blood flow volumes per second of Pop.V and CFV
Control
(n = 66)
EMS (n = 93)
At rest During EMS
Peak venous flow velocity (cm/s)
Right Pop.V 15.3 (11.3–26.0) 10.2 (7.6–14.0)# 24.3 (15.1–40.8)*#
Left Pop.V 13.3 (10.4–21.0) 10.9 (8.2–16.4) 24.9 (15.4–36.4)*#
Right CFV 20.4 (15.8–27.0) 16.3 (11.9–24.8) 25.1 (17.0–32.6)*
Left CFV 20.6 (16.2–28.6) 17.3 (13.8–23.3) 23.0 (18.2–34.3)*
Venous diameter (mm)
Right Pop.V 6.8 (6.0–7.7) 6.9 (6.1–8.0) 7.3 (6.1–7.8)
Left Pop.V 6.9 (6.6–7.8) 7.0 (6.0–7.8) 7.2 (6.2–8.0)
Right CFV 11.0 (10.0–12.8) 10.2 (8.6–11.7)# 10.3 (9.2–11.7)
Left CFV 11.0 (9.8–12.7) 10.4 (9.2–12.0) 10.2 (8.9–12.0)
Blood flow volume (cm3/s)
Right Pop.V 5.5 (3.6–9.0) 4.0 (2.5–7.2) 9.3 (5.3–14.7)*#
Left Pop.V 5.2 (3.4–8.2) 4.7 (2.9–7.2) 8.4 (5.5–16.9)*#
Right CFV 20.0 (12.4–35.0) 12.8 (9.4–19.6)# 20.8 (12.2–32.3)*
Left CFV 19.0 (12.7–35.4) 13.0 (10.7–22.4)# 20.9 (12.4–37.3)*
Abbreviations: CFV common femoral vein, EMS electrical muscle stimulation,
Pop.V popliteal vein
Values are presented as median (IQR)
*Statistical difference compared with at rest in the EMS group
patients (p < 0.05)
#Statistical difference compared with control patients (p < 0.05)
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